Roivant Sciences ROIV
NASDAQ ROIV
$42.17 +0.69 (+1.65%)
As of: Sep 9, 2026 · 1:41 PM EDT

Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2026)

Roivant Sciences' (ROIV) quarterly Change in Acquisitions & Divestments came in at $568.2 million in Q2 2026, down 21.08% on a YoY basis from $720.0 million in Q2 2025, and down 79.3% quarter-over-quarter from $2.7 billion in Q4 2025.

Analysis

Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $568.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Acquisitions & Divestments fell 21.08% year-over-year to $568.2 million; the trailing twelve-month figure through Jun 2026 stood at $5.1 billion (up 205.84% YoY), and the FY2026 full-year result was $2.2 billion, up 11.48% from the prior year.
  • Change in Acquisitions & Divestments slipped to $568.2 million in Q2 2026 per ROIV's latest filing, from $2.7 billion in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $2.7 billion in Q4 2025 and bottomed at $568.2 million in Q2 2026.
  • Historically, Change in Acquisitions & Divestments has averaged $1.2 billion across 3 years, with a median of $960.0 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments soared 185.94% in 2025, then dropped 21.08% in 2026.
  • Over 3 years, Change in Acquisitions & Divestments stood at $960.0 million in 2024, then jumped by 185.94% to $2.7 billion in 2025, then slumped by 79.3% to $568.2 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $568.2 million, $2.7 billion, and $1.1 billion for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.69 Bn 196.70 Bn 7.24 Bn
2 Gilead Sciences 181.20 Bn 178.03 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.15 Bn 124.29 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.89 Bn 3.93 Bn
5 Argenx Se 61.70 Bn 56.51 Bn 1.37 Bn
6 Moderna 54.73 Bn 49.59 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.11 Bn 30.80 Bn 992.69 Mn
8 Biogen 31.27 Bn 29.99 Bn 1.96 Bn
9 Roivant Sciences 30.38 Bn 30.38 Bn 1.16 Mn
10 Insmed 28.13 Bn 26.97 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 568.19 Mn
Dec 31, 2025 2.75 Bn
Sep 30, 2025 1.11 Bn
Jun 30, 2025 720.00 Mn
Dec 31, 2024 960.00 Mn
Dec 31, 2021 320.17 Mn
Dec 31, 2020 -320.17 Mn